Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does REPAGLINIDE Cause Hepatic function abnormal? 9 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Hepatic function abnormal have been filed in association with REPAGLINIDE (Repaglinide). This represents 0.4% of all adverse event reports for REPAGLINIDE.

9
Reports of Hepatic function abnormal with REPAGLINIDE
0.4%
of all REPAGLINIDE reports
2
Deaths
4
Hospitalizations

How Dangerous Is Hepatic function abnormal From REPAGLINIDE?

Of the 9 reports, 2 (22.2%) resulted in death, 4 (44.4%) required hospitalization.

Is Hepatic function abnormal Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for REPAGLINIDE. However, 9 reports have been filed with the FAERS database.

What Other Side Effects Does REPAGLINIDE Cause?

Hypoglycaemia (665) Acute kidney injury (281) Lactic acidosis (163) Hypoglycaemic coma (125) Sopor (91) Confusional state (89) Drug interaction (89) Blood glucose increased (88) Diarrhoea (87) Dyspnoea (87)

What Other Drugs Cause Hepatic function abnormal?

NIVOLUMAB (1,131) PEMBROLIZUMAB (1,079) METHOTREXATE (1,054) CABOZANTINIB S-MALATE (912) CYCLOPHOSPHAMIDE (824) BEVACIZUMAB (769) PACLITAXEL (603) LENVATINIB (528) ATORVASTATIN (520) CYCLOSPORINE (508)

Which REPAGLINIDE Alternatives Have Lower Hepatic function abnormal Risk?

REPAGLINIDE vs REPOTRECTINIB REPAGLINIDE vs REQUIP REPAGLINIDE vs RESLIZUMAB REPAGLINIDE vs RESMETIROM REPAGLINIDE vs RESTASIS

Related Pages

REPAGLINIDE Full Profile All Hepatic function abnormal Reports All Drugs Causing Hepatic function abnormal REPAGLINIDE Demographics